Catanzaro Calogero, Falkenbach Fabian, Marmiroli Andrea, Longoni Mattia, Le Quynh Chi, Nicolazzini Michele, Polverino Federico, Goyal Jordan A, Bianchi Lorenzo, Piazza Pietro, Mottaran Angelo, Saad Fred, Shariat Shahrokh F, Graefen Markus, Ferro Matteo, Briganti Alberto, Chun Felix K H, Volpe Alessandro, Longo Nicola, Schiavina Riccardo, Karakiewicz Pierre I
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Ann Surg Oncol. 2025 Jul 12. doi: 10.1245/s10434-025-17769-w.
The effect of valvulopathy on adverse in-hospital outcomes after partial nephrectomy (PN) and radical nephrectomy (RN) is unknown.
Descriptive analyses, 1:2 propensity score matching and multivariable logistic and Poisson regression models were used to address National Inpatient Sample (2000-2019) patients with kidney cancer who underwent PN and RN, stratified according to presence or absence of valvulopathy.
Overall, 38,673 patients underwent PN versus 92,072 RN. Of those, 836 (2.2%) and 2651 (2.9%) had valvulopathy, respectively. Valvulopathy rate decreased from 3.04 to 1.57% in PN patients (2000-2019, EAPC: -1.74%, p = 0.02), and from 2.97 to 2.28% in RN patients (2000-2019, EAPC: -0.94%, p = 0.01). RN patients with valvulopathy were older and carried a higher number of comorbidities than PN patients with valvulopathy. Valvulopathy in PN patients independently predicted higher rates of adverse in-hospital outcomes in 7 of 14 examined categories, with odds ratio (OR) ranging from 2.96 for cardiac complications to 2.35 for vascular complications and 1.78 for bleeding complications (all p < 0.05), but not in-hospital mortality (p > 0.05). Valvulopathy in RN patients independently predicted higher rates of adverse in-hospital outcomes in 9 of 14 examined categories, with OR ranging from 2.88 for cardiac complications to 1.83 for vascular complications and 1.43 for overall complications (all p < 0.05), but not in-hospital mortality (p > 0.05).
Patients with valvulopathy treated with RN are generally older and present with more baseline comorbidities. In this population, RN is associated with a higher risk of adverse in-hospital outcomes compared with PN when examining the impact of valvulopathy on such outcomes.
瓣膜病对部分肾切除术(PN)和根治性肾切除术(RN)后不良院内结局的影响尚不清楚。
采用描述性分析、1:2倾向评分匹配以及多变量逻辑回归和泊松回归模型,对国家住院患者样本(2000 - 2019年)中接受PN和RN的肾癌患者进行分析,根据是否存在瓣膜病进行分层。
总体而言,38,673例患者接受了PN,92,072例接受了RN。其中,分别有836例(2.2%)和2651例(2.9%)患有瓣膜病。PN患者的瓣膜病发生率从2000年的3.04%降至2019年的1.57%(EAPC:-1.74%,p = 0.02),RN患者的瓣膜病发生率从2.97%降至2.28%(2000 - 2019年,EAPC:-0.94%,p = 0.01)。患有瓣膜病的RN患者比患有瓣膜病的PN患者年龄更大,合并症更多。PN患者中的瓣膜病在14个检查类别中的7个类别中独立预测了更高的不良院内结局发生率,比值比(OR)范围从心脏并发症的2.96到血管并发症的2.35以及出血并发症的1.78(均p < 0.05),但对院内死亡率无影响(p > 0.05)。RN患者中的瓣膜病在14个检查类别中的9个类别中独立预测了更高的不良院内结局发生率,OR范围从心脏并发症的2.88到血管并发症的1.83以及总体并发症的1.43(均p < 0.05),但对院内死亡率无影响(p > 0.05)。
接受RN治疗的瓣膜病患者通常年龄更大,基线合并症更多。在这一人群中,在研究瓣膜病对院内结局的影响时,与PN相比,RN与更高的不良院内结局风险相关。